The discovery, which focused on a protein called CD2AP, could dramatically change how the disease is perceived and treated, says the study's principal investigator, Dr. Minh Dang Nguyen, Ph.D., a ...

A new strategy for delivering bulky PROTACs to cancerous cells successfully utilizes the CD36 protein pathway on cells’ surfaces.

Researchers at the Francis Crick Institute and Barts Cancer Institute, Queen Mary University of London, have shown that the ...